Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Gregory Lee was professor at University of British Columbia in Vancouver, Canada until 2012. He received his PhD in physical biochemistry from California Institute of Technology Pasadena, CA in 1972. His major research interest is in the field of biotechnology. He has generated numerous monoclonal antibodies for immunodiagnostic and therapeutic applications, including the early pregnancy detection, ovulation, myocardial infarction and cancer. During the last decade, he has been focused on research and development of the monoclonal antibody-based anti-cancer drugs (noticeably RP215 and GHR106) for immunotherapy of human cancer. He has been serving as editors of several international journals related to cancer research since 2012.
He has been focused on research and development of the monoclonal antibody-based anti-cancer drugs (noticeably RP215 and GHR106) for immunotherapy of human cancer.
|Review Article: J Clin Cell Immunol 2015, 6: 385|
|Review Article: J Clin Cell Immunol 2014, 5: 279|
|Gregory Lee, Cheng-Yuan Huang, Yiting Tang and Hao Zhang|
|Research Article: J Clin Cell Immunol 2014, 5: 200|
|Gregory Lee, Cheng-yuan Huang and Bixia Ge|
|Review Article: J Cancer Sci Ther/Vol.6.3 110-116 (2014)|
|Yiting Tang, Hao Zhang and Gregory Lee|
|Research Article: J Cancer Sci Ther/Vol.5.5 200-208 (2013)|
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals